AnaCardio
AnaCardio develops oral medicines intended to improve heart muscle contraction in people with heart failure.
€62.5MSeries B
ParticipantSB
Sound Bioventures
Activity from announced rounds
Activity in this selectionred-bike-capital-2cbe4050
- Rounds participated in
- 1
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $71M 1 disclosed · full round size, not this investor’s share